# Consequences of Changing Current Standards: Endocrine Status After Routine Fallopian Tube Removal

> **NCT02669498** · NA · COMPLETED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 128 (actual)

## Conditions studied

- Pelvic Surgery
- Routine Fallopian Tube Removal

## Interventions

- **PROCEDURE:** Routine fallopian tube removal

## Key facts

- **NCT ID:** NCT02669498
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-01
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2022-09-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02669498

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02669498, "Consequences of Changing Current Standards: Endocrine Status After Routine Fallopian Tube Removal". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02669498. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*